Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDGoodRx Holdings Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 8 | $0.05 | $0.09 | $0.07 |
| Q2 2026 | 7 | $0.07 | $0.10 | $0.08 |
| Q3 2026 | 7 | $0.06 | $0.09 | $0.08 |
| Q4 2026 | 3 | $0.08 | $0.08 | $0.08 |
| Q1 2027 | 3 | $0.08 | $0.08 | $0.08 |
| Q2 2027 | 2 | $0.10 | $0.10 | $0.10 |
| Q3 2027 | 2 | $0.10 | $0.10 | $0.10 |
| Q4 2027 | 2 | $0.10 | $0.11 | $0.11 |
| Q1 2028 | 3 | $0.11 | $0.11 | $0.11 |
| Q2 2028 | 6 | $0.13 | $0.13 | $0.13 |
| Q3 2028 | 5 | $0.14 | $0.14 | $0.14 |
| Q4 2028 | 5 | $0.13 | $0.14 | $0.14 |
GoodRx Holdings Inc Earnings Date And Information
GoodRx Holdings Inc last posted its earnings results on Wednesday, May 6th, 2026. The company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.07 by $0. The company had revenue of 194.01 M for the quarter and had revenue of 796.85 M for the year. GoodRx Holdings Inc has generated $0 earnings per share over the last year ($0.0853 diluted earnings per share) and currently has a price-to-earnings ratio of 31.06. GoodRx Holdings Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
GoodRx Holdings Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/06/2026 | Q1 2026 | $0.07 | $0.03 | -0.04 | $185.40 M | $194.01 M |
| 02/25/2026 | Q4 2025 | $0.09 | $0.02 | -0.07 | $193.27 M | $194.79 M |
| 11/04/2025 | Q3 2025 | $0.09 | $0.00 | -0.09 | $194.54 M | $196.03 M |
| 08/06/2025 | Q2 2025 | $0.10 | $0.04 | -0.06 | $205.90 M | $203.07 M |
| 05/07/2025 | Q1 2025 | $0.09 | $0.03 | -0.06 | $202.22 M | $202.97 M |
| 02/27/2025 | Q4 2024 | $0.10 | $0.02 | -0.08 | $199.76 M | $198.58 M |
| 11/07/2024 | Q3 2024 | $0.09 | $0.03 | -0.06 | $195.66 M | $195.25 M |
| 08/08/2024 | Q2 2024 | $0.09 | $0.02 | -0.07 | $200.47 M | $200.61 M |
| 05/09/2024 | Q1 2024 | $0.09 | -$0.00 | -0.09 | $196.11 M | $197.88 M |
| 02/29/2024 | Q4 2023 | $0.08 | -$0.06 | -0.14 | N/A | $196.64 M |
| 11/09/2023 | Q3 2023 | $0.06 | -$0.09 | -0.15 | N/A | $179.96 M |
| 08/09/2023 | Q2 2023 | $0.06 | $0.14 | 0.08 | N/A | $189.68 M |
| 05/10/2023 | Q1 2023 | $0.06 | -$0.01 | -0.07 | N/A | $183.99 M |
| 02/28/2023 | Q4 2022 | N/A | -$0.00 | N/A | N/A | $184.11 M |
| 11/08/2022 | Q3 2022 | N/A | -$0.10 | N/A | N/A | $187.32 M |
| 08/08/2022 | Q2 2022 | N/A | -$0.00 | N/A | N/A | $191.80 M |
| 05/09/2022 | Q1 2022 | N/A | $0.03 | N/A | N/A | $203.33 M |
| 02/28/2022 | Q4 2021 | N/A | -$0.10 | N/A | N/A | $213.26 M |
| 11/10/2021 | Q3 2021 | N/A | -$0.04 | N/A | N/A | $195.10 M |
| 08/12/2021 | Q2 2021 | $0.08 | $0.08 | 0 | N/A | $176.64 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
GoodRx Holdings Inc Earnings: FAQ's
The conference call for GoodRx Holdings Inc's latest earnings report can be listened to online.
The conference call transcript for GoodRx Holdings Inc's latest earnings report can be read online.
GoodRx Holdings Inc (:GDRX) has a recorded annual revenue of $796.85 M.
GoodRx Holdings Inc (:GDRX) has a recorded net income of $30.44 M.GoodRx Holdings Inc has generated $0.0854 earnings per share over the last four quarters.
GoodRx Holdings Inc (:GDRX) has a price-to-earnings ratio of 31.06 and price/earnings-to-growth ratio is -2.06.